April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Melatonin Prevents Functional and Histological Alterations in an Experimental Model of Glaucoma in Rats
Author Affiliations & Notes
  • R. E. Rosenstein
    Dept Human Biochem-Sch Med/ UBA-CEFyBO/CONICET, University of Buenos Aires, Buenos Aires, Argentina
  • N. Belforte
    Dept Human Biochem-Sch Med/ UBA-CEFyBO/CONICET, University of Buenos Aires, Buenos Aires, Argentina
  • N. de Zavalía
    Dept Human Biochem-Sch Med/ UBA-CEFyBO/CONICET, University of Buenos Aires, Buenos Aires, Argentina
  • M. I. Keller Sarmiento
    Dept Human Biochem-Sch Med/ UBA-CEFyBO/CONICET, University of Buenos Aires, Buenos Aires, Argentina
  • M. C. Moreno
    Dept Human Biochem-Sch Med/ UBA-CEFyBO/CONICET, University of Buenos Aires, Buenos Aires, Argentina
  • Footnotes
    Commercial Relationships  R.E. Rosenstein, None; N. Belforte, None; N. de Zavalía, None; M.I. Keller Sarmiento, None; M.C. Moreno, None.
  • Footnotes
    Support  Ruth Rosenstein, BID 1728 PICT 25364
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 2765. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R. E. Rosenstein, N. Belforte, N. de Zavalía, M. I. Keller Sarmiento, M. C. Moreno; Melatonin Prevents Functional and Histological Alterations in an Experimental Model of Glaucoma in Rats. Invest. Ophthalmol. Vis. Sci. 2009;50(13):2765.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : An increase in retinal glutamate and nitric oxide levels, as well as oxidative damage could be involved in glaucomatous neuropathy. The aim of the present work was to investigate the effect of melatonin on these parameters as well as on functional and histological alterations in an experimental model of glaucoma induced by chronic injections of hyaluronic acid (HA)

Methods: : In retinas from normotensive eyes, glutamate uptake and glutaminase activity were assessed using 3H-glutamate and 3H-glutamine, respectively. NOS activity was measured through the conversion of 3H-arginine to 3H-citrulline. Superoxide dismutase (SOD), glutamine synthetase (GS) activity, and reduced glutathione levels (GSH) were measured by spectrophotometric methods, while thiobarbituric acid reactive substances (TBARS) levels were determined as an index of lipid peroxidation. On the other hand, weekly injections of HA were performed unilaterally in the rat anterior chamber, whereas the contralateral eye was injected with saline solution. A pellet of 5 mg melatonin was implanted subcutaneously two hours before the first injection of HA. The pellet of melatonin was replaced every 15 days. After 6 or 10 weeks of ocular hypertension retinal function was assessed by electroretinography, and the ganglion cell layer cells number was measured.

Results: : Melatonin increased glutamate uptake, GS and SOD activities, as well as GSH levels. Moreover, melatonin decreased glutaminase and NOS activities and lipid peroxidation. On the other hand, melatonin significantly prevented the electroretinographic dysfunction and the decrease in the number of retinal ganglion cells induced by ocular hypertension

Conclusions: : The chronic treatment with melatonin prevented functional alterations and diminished the vulnerability of retinal ganglion cells to the deleterious effects of ocular hypertension, probably by antagonizing the effect of ocular hypertension on glutamatergic and nitridergic systems and on oxidative damage. Therefore, these results indicate that melatonin could be a promissory resource in the management of glaucoma

Keywords: melatonin • neuroprotection • retina: neurochemistry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×